Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari  Date: 2020-08-13

Medtronic to acquire Companion Medical to expand diabetes business

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical.

The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, which is the first US FDA-cleared smart insulin pen device combined with an optimized diabetes care app manufactured by the privately held company.

The introduction of the InPen to the Medtronic portfolio strengthens the company’s ability to provide a special and comprehensive service system, irrespective of how insulin is administered, to patients where they are in their progression through diabetes. 

Companion Medical's purchase builds on previous Medtronic acquisitions, including Nutrino and Klue, which form foundations for the construction of efficient algorithms that leverage the advanced data science and AI capabilities of the organization. 

Medtronic will collaborate through this new investment to further automate insights and dosing capacities to reduce affecting factors irrespective of the technology chosen for insulin transmission. Additionally, the deal assists Medtronic's plan extends to InPen's worldwide distribution.

Sources cite that the acquisition will be concluded within one to two months, provided all usual closing conditions are met. This is estimated that the deal would be favorable to, and accretive to, Medtronic's adjusted income per share during the current fiscal year. This will also follow the long-term financial benchmarks of Medtronic for acquisitions.

Sean Salmon, executive vice president and president of the Diabetes Group at Medtronic highlighted the firm's goal to find a trusted partner that offers support for an individual's preferences whether they want to stay on MDI, take on automated insulin or refrain from using their pump for some time. 

Highlighting the InPen, Sean said that the company is looking forward to expanding InPen's success by integrating it with smart algorithms to provide customized, constructive dosing guidance. This smart CGM machine can make people careless of diabetes and lead their own lives independently, he added.

Sean Saint, CEO, and co-founder of Companion Medical shared his excitement and stated that they are excited to bring together abilities and product offerings to support ever more diabetes-induced citizens around the globe.

Source Credit - https://www.businesswire.com/news/home/20200811005363/en/Bayer-Acquire-UK-Based-Biotech-KaNDy-Therapeutics-Ltd

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Telus Communications selects Nokia to deliver 5G services in Canada
Telus Communications selects Nokia to deliver 5G services in Canada
By Akshay Kedari

According to reliable sources, Nokia Corporation has reportedly been selected by Canada-based Telus Communications Inc. to provide 5G services in Canada. The Finnish multinational technology giant will reportedly support the Canadian mobile service o...

TBI, Oracle to jointly launch cloud-based vaccine management system
TBI, Oracle to jointly launch cloud-based vaccine management system
By Akshay Kedari

Tony Blair Institute (TBI) and Oracle have recently introduced cloud technology to Africa for effective management of public health programs in the region. As per credible sources, initially, Ghana, Sierra Leone and Rwanda will use the new Oracl...

Minerva Bunkering unveils ADP for better clarity in bunker deliveries
Minerva Bunkering unveils ADP for better clarity in bunker deliveries
By Akshay Kedari

Swiss supplier of marine fuels Minerva Bunkering has reportedly introduced an innovative solution called Advanced Delivery Platform (ADP) in a bid to increase efficiency and transparency during bunkering operations. According to reliable sources, Min...

TestGorilla secures $1.2M in CapitalT-led pre-Series A funding round
TestGorilla secures $1.2M in CapitalT-led pre-Series A funding round
By Akshay Kedari

In a pre-Series A funding initiative led by a consortium of international angel investors and CapitalT, pre-employment testing software player, TestGorilla, has reportedly secured an amount of USD 1.2 million. This announcement comes amid TestGorilla...

AEGIS Hedging acquires Nexidus Commodities, debuts in metal hedging
AEGIS Hedging acquires Nexidus Commodities, debuts in metal hedging
By Akshay Kedari

AEGIS Hedging Solutions a leading company offering technology and expertise for commodity and rate hedging, has recently announced the acquisition of a renowned commodity trading advisor and pioneer in metals hedging, Nexidus Commodities. Speaking o...